BRCA2 and posterior cortical atrophy: Hence, as has previously been suggested [11], it is possible that the lower PCa risks observed for Ashkenazi BRCA2 carriers [3, 4, 6, 7, 11, 12, 30, 33, 45] is explained by risk variation by the location of PVs within the BRCA2 gene.